Illumina Total Cost of Revenue decreased by 7.5% to $370.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 3.4%, from $358.00M to $370.00M. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows relatively stable performance with a 1.8% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $324.00M | $338.00M | $382.00M | $408.00M | $395.00M | $398.00M | $411.00M | $432.00M | $444.00M | $435.00M | $448.00M | $409.00M | $391.00M | $335.00M | $376.00M | $358.00M | $364.00M | $351.00M | $400.00M | $370.00M |
| QoQ Change | — | +4.3% | +13.0% | +6.8% | -3.2% | +0.8% | +3.3% | +5.1% | +2.8% | -2.0% | +3.0% | -8.7% | -4.4% | -14.3% | +12.2% | -4.8% | +1.7% | -3.6% | +14.0% | -7.5% |
| YoY Change | — | — | — | — | +21.9% | +17.8% | +7.6% | +5.9% | +12.4% | +9.3% | +9.0% | -5.3% | -11.9% | -23.0% | -16.1% | -12.5% | -6.9% | +4.8% | +6.4% | +3.4% |
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Service | $95.00M | $84.00M | $81.00M | $88.00M | $71.00M | $68.00M | $72.00M | $80.00M |
| Total | $391.00M | $335.00M | $376.00M | $358.00M | $364.00M | $351.00M | $400.00M | $370.00M |
Service and other revenue was previously reported and has since been discontinued or reclassified. Only currently active segments are shown in the chart.
| Segment | Q1 '25 |
|---|---|
| Core Illumina | $358.00M |
| Total | $358.00M |